There is no RationalWiki without you. We are a small non-profit with no staff — we are hundreds of volunteers who document pseudoscience and crankery around the world every day. We will never allow ads because we must remain independent. We cannot rely on big donors with corresponding big agendas. We are not the largest website around, but we believe we play an important role in defending truth and objectivity.
If everyone seeing this today donates $5, we will meet our goal for 2018.
| Fighting pseudoscience isn't free.|
We are 100% user-supported! Help and donate $5, $20 or whatever you can today with !
Cantron is yet another odious piece of cancer woo. Other names it is sold under include Cancell, Protocel, Sheridan's Formula, Jim's Juice, Crocinic Acid, JS–114, JS–101, 126–F and Entelev.
It was invented by crank biochemist James V. Sheridan with the aim of targeting the anaerobic cell respiration of cancer cells, in accordance with the now-outmoded Warburg hypothesis (that cancer happens when cells make energy anaerobically, rather than by mutation or activation of oncogenes). Thus, it originated in the sort of pseudoscience that holds that an invalidated hypothesis is valid.
The precise formula is secret. The FDA lists the components as inositol, nitric acid, sodium sulfite, potassium hydroxide, sulfuric acid and catechol. The nonexistent "crocinic acid" was originally listed as an ingredient.
None. The National Cancer Institute tested the constituents in animal experiments in 1978 and 1980 and in vitro on human tumors in 1990 and 1991, and concluded that the ingredients could not be taken in doses high enough to kill cancer cells in the body, and that further study was not warranted.
The American Cancer Society recommends against bothering with it.
There appear to be no tests on the secret formulation itself, which is a nice escape hatch.
- "Questionable methods of cancer management: Cancell/Entelev." CA Cancer J Clin 43 (1): 57–62. 1993. doi:10.3322/canjclin.43.1.57. PMID 8422607.
- Segal, Marian. "Court says to cancel the CanCell". FDA Consumer (May 1993: Federal Drug Administration) 27 (4). ISSN 0362-1332.